Baird Medical Investment Holdings (BDMD) Non-Current Deferred Tax Liability (2023 - 2026)
Baird Medical Investment Holdings' (BDMD) quarterly Non-Current Deferred Tax Liability came in at $6500.0 in Q2 2026, down 69.85% year-over-year from $21559.0 in Q2 2025, and down 25.78% quarter-over-quarter from $8758.0 in Q4 2025.
Analysis
Baird Medical Investment Holdings (BDMD) Non-Current Deferred Tax Liability (2023 - 2026) Analysis & Trends
Baird Medical Investment Holdings (BDMD) has reported Non-Current Deferred Tax Liability for 4 consecutive years, with $6500.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 69.85% year-over-year to $6500.0 in Q2 2026; TTM through Jun 2026 was $6500.0, a 69.85% decrease from a year earlier, with the FY2025 full-year figure at $8758.0, down 80.64% from the prior year.
- Non-Current Deferred Tax Liability was $6500.0 for Q2 2026 at Baird Medical Investment Holdings, down from $8758.0 in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $93389.0 in Q4 2023 and troughed at $6500.0 in Q2 2026.
- A 4-year average of $35088.8 and a median of $21559.0 in 2025 frame the typical range for Non-Current Deferred Tax Liability.
- Across the five-year window, Non-Current Deferred Tax Liability tumbled 51.56% in 2024 and sank 80.64% in 2025, its largest moves.
- Over 4 years, Non-Current Deferred Tax Liability stood at $93389.0 in 2023, then plunged by 51.56% to $45238.0 in 2024, then slumped by 80.64% to $8758.0 in 2025, then declined by 25.78% to $6500.0 in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $6500.0 (Q2 2026), $8758.0 (Q4 2025), and $21559.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Baird Medical Investment Holdings | 29.74 Mn | 29.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,500.00 |
| Dec 31, 2025 | 8,758.00 |
| Jun 30, 2025 | 21,559.00 |
| Dec 31, 2024 | 45,238.00 |
| Dec 31, 2023 | 93,389.00 |